In summary, our current study showed that miR-224 up-regulation could promote ESCC development, possibly through inhibiting PHLPP1 and PHLPP2 expression, indicating that miR-224 has oncogenic activity in ESCC. The gene discussed is PHLPP1; the disease is esophageal squamous cell carcinoma.